Catalyst Pharmaceuticals Inc (STU:CN2)
€ 20.71 0.15 (0.73%) Market Cap: 2.46 Bil Enterprise Value: 2.04 Bil PE Ratio: 18.19 PB Ratio: 3.87 GF Score: 88/100

Q4 2020 Catalyst Pharmaceuticals Inc Earnings Call Transcript

Mar 16, 2021 / 12:30PM GMT
Release Date Price: €3.41 (+6.32%)
Operator

Greetings, and welcome to the Catalyst Pharmaceuticals Fourth Quarter and Fiscal Year 2020 Financial Results Conference Call.

(Operator Instructions)

As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Ms. Ali Grande, Chief Financial Officer. Thank you. Please go ahead.

Alicia Grande
Catalyst Pharmaceuticals, Inc. - VP, Treasurer & CFO

Good morning, everyone, and thank you for joining our conference call to discuss Catalyst's fourth quarter and full year 2020 financial results and corporate highlights. Speakers on today's call, we have Patrick McEnany, Chairman and Chief Executive Officer; Dr. Steven Miller, Chief Operating Officer and Chief Scientific Officer; and Jeffrey Del Carmen, Chief Commercial Officer. Joining the Q&A we'll also have Mr. Gary Ingenito, Chief Medical and Regulatory Officer.

Before we begin, I would like to remind you that in the following comments and in the Q&A session, we will make statements about expected future results, which may be forward-looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot